Literature DB >> 737908

Selective decrease in antibody-dependent cell-mediated cytotoxicity in systemic lupus erythematosus and progressive systemic sclerosis.

S M Cooper, B Harding, G R Mirick, J Schneider, F P Quismorio, G J Friou.   

Abstract

With the use of two target cells (chicken erythrocytes and Chang cells), the antibody-dependent cell-mediated cytotoxicity (ADCMC) of peripheral blood mononuclear cells from patients with systemic lupus erythematosus (SLE) and progressive systemic sclerosis (PSS) was studied. Patients with active SLE had a significant reduction in ADCMC against Chang cells whereas cytotoxicity against chicken erythrocytes did not differ significantly from that of a control population. Similarly, a group of PSS patients with positive anti-DNP antibodies demonstrated a selective reduction in ADCMC against Chang cells. These findings support the concept that different effector cells mediate ADCMC against chicken erythrocytes and Chang cells, and indicate that in some patients with SLE and PSS there is a selective reduction or blockade of the ADCMC effector cell active against Chang cells.

Entities:  

Mesh:

Year:  1978        PMID: 737908      PMCID: PMC1537498     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  21 in total

1.  The effector cells in human peripheral blood mediating mitogen-induced cellular cytotoxicity and antibody-dependent cellular cytotoxicity.

Authors:  D L Nelson; B M Bundy; H E Pitchon; R M Blaese; W Strober
Journal:  J Immunol       Date:  1976-11       Impact factor: 5.422

2.  Characteristics of the effector cells mediating cytotoxicity against antibody-coated target cells. II. The mouse nonadherent K cell.

Authors:  A H Greenberg; L Shen; L Walker; A Arnaiz-Villena; I M Roitt
Journal:  Eur J Immunol       Date:  1976-07       Impact factor: 5.532

3.  Two populations of lymphocytes involved in phytohaemagglutinin-induced cytotoxicity of a dividing target cell.

Authors:  C A Waller; A C Campbell; I C MacLennan
Journal:  Scand J Immunol       Date:  1976       Impact factor: 3.487

4.  Lymphocyte-dependent cytotoxic antibody activity against human transplantation antigens.

Authors:  P Hersey; P Cullen; I C MacLennan
Journal:  Transplantation       Date:  1973-07       Impact factor: 4.939

5.  Isolation of separate Fc receptors for IgG complexed to antigen and native IgG from a murine leukaemia.

Authors:  S M Cooper; Y Sambray; G J Frious
Journal:  Nature       Date:  1977-11-17       Impact factor: 49.962

6.  Low affinity E-rosette formation by the human K cell.

Authors:  W H West; R B Boozer; R B Herberman
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

7.  Mixed connective tissue disease--an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA).

Authors:  G C Sharp; W S Irvin; E M Tan; R G Gould; H R Holman
Journal:  Am J Med       Date:  1972-02       Impact factor: 4.965

8.  In vitro activity of anti-DNA antibodies from SLE patients in antibody-dependent cell-mediated cytotoxicity.

Authors:  F P Quismorio; G J Friou; J Schneider; M Hutchinson; B Harding
Journal:  Int Arch Allergy Appl Immunol       Date:  1976

9.  Human antibody-dependent cellular cytotoxicity. Isolation and identification of a subpopulation of peripheral blood lymphocytes which kill antibody-coated autologous target cells.

Authors:  A M Brier; L Chess; S F Schlossman
Journal:  J Clin Invest       Date:  1975-12       Impact factor: 14.808

10.  CONTACT-INDUCED CYTOTOXICITY BY LYMPHOID CELLS CONTAINING FOREIGN ISOANTIGENS.

Authors:  E MOELLER
Journal:  Science       Date:  1965-02-19       Impact factor: 47.728

View more
  7 in total

Review 1.  Pathogenesis of scleroderma: the interrelationship of the immune and vascular hypotheses.

Authors:  E M Sternberg
Journal:  Surv Immunol Res       Date:  1985

2.  Impaired primary in-vitro antibody response in progressive systemic sclerosis patients: rôle of suppressor monocytes.

Authors:  P Segond; D Salliere; P Galanaud; R M Desmottes; P Massias; J N Fiessinger
Journal:  Clin Exp Immunol       Date:  1982-01       Impact factor: 4.330

3.  Antibody-dependent cellular cytotoxicity in recurrent aphthous ulceration.

Authors:  J S Greenspan; N Gadol; J A Olson; N Talal
Journal:  Clin Exp Immunol       Date:  1981-06       Impact factor: 4.330

4.  Defective Epstein-Barr virus specific suppressor T cell function in progressive systemic sclerosis.

Authors:  A Kahan; A Kahan; C J Menkes; B Amor
Journal:  Ann Rheum Dis       Date:  1986-07       Impact factor: 19.103

5.  Antibody-dependent and phytohaemagglutinin-induced lymphocyte cytotoxicity in systemic lupus erythematosus.

Authors:  J K Wright; P Hughes; K Gelsthorpe; A M Ward; N R Rowell
Journal:  Ann Rheum Dis       Date:  1981-02       Impact factor: 19.103

6.  Monocyte-induced inhibition of lymphocyte response to phytohaemagglutinin in progressive systemic sclerosis.

Authors:  M D Lockshin; J A Markenson; L Fuzesi; S Kazanjian-Aram; C Joachim; M Ordene
Journal:  Ann Rheum Dis       Date:  1983-02       Impact factor: 19.103

7.  Antibody dependent cell-mediated cytotoxicity in different forms of rheumatoid arthritis patients.

Authors:  B Misiewicz-Poltorak; M Plachecka-Gutowska
Journal:  Clin Rheumatol       Date:  1984-09       Impact factor: 2.980

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.